Evidence map›Paper›PMID 30880973›Full record

ArticleInternational journal of nanomedicine2019

Assessing human exposure risk and lung disease burden posed by airborne silver nanoparticles emitted by consumer spray products.

Ying-Fei Yang, Wei-Ming Wang, Chi-Yun Chen, Tien-Hsuan Lu, Chung-Min Liao

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Toxicologic Concerns with Current Medical Nanoparticles.International journal of molecular sciences · 2022
    Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ying-Fei YangDepartment of Bioenvironmental Systems Engineering, National Taiwan University, Taipei, Taiwan 10617, Republic of China, cmliao@ntu.edu.tw.
Wei-Ming WangDepartment of Bioenvironmental Systems Engineering, National Taiwan University, Taipei, Taiwan 10617, Republic of China, cmliao@ntu.edu.tw.
Chi-Yun ChenDepartment of Bioenvironmental Systems Engineering, National Taiwan University, Taipei, Taiwan 10617, Republic of China, cmliao@ntu.edu.tw.
Tien-Hsuan LuDepartment of Bioenvironmental Systems Engineering, National Taiwan University, Taipei, Taiwan 10617, Republic of China, cmliao@ntu.edu.tw.
Chung-Min LiaoDepartment of Bioenvironmental Systems Engineering, National Taiwan University, Taipei, Taiwan 10617, Republic of China, cmliao@ntu.edu.tw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNo systematic investigations have been conducted to assess the lung burden imposed by the chronic inhalation of silver nanoparticles (AgNPs) emitted by spray products.

objectiveThe objective of this study was to formulate a study framework that integrates a probabilistic risk assessment scheme with a mechanistic lung burden model for the estimation of health risks associated with the long-term inhalation of AgNP-containing spray products. MATERIALS AND

methodsA compartmentalized physiologically based alveolar deposition (PBAD) model was used to estimate AgNP lung burden. Dose-response relationships were established using nanotoxicity data sets obtained from rats (as a model organism). Weibull model-based thresholds of AgNP lung burden based on neutrophil-elevated inflammation bio-markers were estimated from Hill-based exposure-response relationships. Finally, the risks of lung disease posed by various AgNP-containing spray products were assessed.

resultsConservative thresholds for the prevention of pulmonary disease were estimated as follows (mean ± SE): 34 nm AgNPs (0.32±0.22 mg) and 60 nm AgNPs (1.08±0.64 mg). Our results indicate that the risk probability was ~0.5 that the hazard quotient (HQ) estimates of deodorant with a count median diameter (CMD) ≈30 nm exceeded 1. The primary risk posed by AgNPs is transferred from the interstitial region to lymph nodes. Under the condition of 50% risk probability, the 97.5 percentile of HQ for the spray products were as follows: CMD ≈30 nm (~3.4) and CMD ≈60 nm (~1.1).

conclusionOur application of the proposed risk assessment scheme to the results obtained in an in vivo animal model proved highly effective in elucidating the relationship between the characteristics of metallic NP-containing spray products and their corresponding toxicity. The integration of the proposed PBAD model with a risk assessment framework enables the rapid assessment of risk posed by spray products containing metallic NPs over various time scales.

Indexed as

Risk AssessmentAdministration, InhalationAerosolsAnimalsEnvironmental ExposureHumansLungLung DiseasesMetal NanoparticlesModels, TheoreticalParticle SizeRatsSilverAerosolsSilverlung burdensnanotoxicityrisk assessmentsilver nanoparticlesspray product

Identifiers

PMID30880973
PMCPMC6407905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.